From the transcript, the following key financial metrics were highlighted:

1. Global revenue for the second quarter was $917.7 million, showing a 2.9% increase from the previous year.
2. Organic growth, adjusted for various factors, was 4.1% for the quarter.
3. Domestic and Canada revenues were $737.7 million, with organic growth of 5.1% after adjustments.
4. International revenues were $180.1 million, showing a decline of 2.7% when adjusted for certain factors.
5. Acquisitions contributed $8.6 million to growth, while divestitures reduced revenues by $0.8 million.
6. Gross profit was $381.8 million, or 41.6% of revenues.
7. Adjusted SG&A excluding amortization was $198.7 million, or 21.6% of revenues.
8. Adjusted income from operations (EBITA) was $183.1 million, or 20% of revenues.
9. Net interest expense was $23.7 million, with an as-reported tax rate of 33.8%.
10. Net loss attributable to Stericycle was $148.8 million, with an adjusted earnings per share of $1.15.
11. Cash from operations for the year-to-date was $237.1 million, or $284.4 million when adjusted for certain items.
12. Year-to-date CapEx was $63.1 million, or 3.5% of revenues.
13. The unpaid balance of the revolver was approximately $676 million.
14. The company repurchased 175,500 shares of mandatory preferred convertible for $12.6 million during the quarter.
15. The annual EPS guidance for 2017 was revised to a range of $4.55 to $4.69.
16. The company is in the design and evaluation phase of its ERP system, with a decision expected by the end of the year.
17. Acquisitions were made in both the United States and internationally, with two in each region.
18. The company achieved 41.6% in gross margin and 20% in EBITA, meeting its operational targets.
19. For the next quarter, the EBITA is expected to be approximately 20.2% moving to about 20.5% for the year.
20. Interest expense is expected to be approximately $100 million, with adjustments based on foreign exchange rates.
21. The EPS guidance for the ComSol and Related Services business contributed about $0.04 favorability.

These financial metrics provide a comprehensive overview of the company's performance, including revenue, profitability, operational targets, and future guidance.